Low market cap, high-growth medical technology company.Based on their revenue guidance Fy23 US dollar $26m-$29m. Year on year revenue growth is expected to exceed 85% in CY24.
Low market cap, high-growth medical technology company.Based on...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.010(3.33%) |
Mkt cap ! $84.59M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.0¢ | 27.5¢ | $25.44K | 88.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 12840 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| NXS (ASX) Chart |